Skip to main content
. 2024 Nov 26;2024(11):CD013707. doi: 10.1002/14651858.CD013707.pub2

7.

7

Networks for outcome 'All adverse events'. Colours distinguish the separate networks. There are three networks, one with levosimendan/placebo/milrinone/milrinone ld/dobutamine, one with milrinone + dobutamine versus levosimendan + dobutamine, and one with levosimendan + milrinone + dopamine versus milrinone + dopamine.

Abbreviation(s)LD: low‐dose